Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

TG Therapeutics begins Phase II trial of TGR-1202 and ibrutinib combination to treat DLBCL

Go Top